“Vigilant” 340B Contract Pharmacy Oversight Is Critical, Pedley Says

by Admin | February 6, 2014 3:05 pm

February 6, 2014—Contract pharmacies “can enable 340B covered entities to expand the type and volume of care they provide to vulnerable patient populations,” the director of the Health Resources and Services Administration (HRSA) Office of Pharmacy (OPA) said today in a public statement[1], but audits have shown that entities’ oversight of contract pharmacies “did not always meet expectations outlined in 340B program guidance.”

You must be registered to read complete articles (it's quick, easy, and 100% free). Click here to register[2]. Already registered? Click here to login[3]. (340B Health members, Drug Discount Monitor subscribers, and 340B Coalition conference attendees: Use your existing username and password.)

Endnotes:

in a public statement: http://www.hrsa.gov/opa/updates/contractpharmacy02052014.pdf
Click here to register: https://secure.340bhealth.org/340Binformed/Subscribe.aspx
Click here to login: http://340binformed.org/reader-login/

Source URL: https://340binformed.org/2014/02/vigilant-340b-contract-pharmacy-oversight-is-critical-pedley-says/